# A&C Foelsgaard Alternativer ApS

> A&C Foelsgaard Alternativer ApS is a VC fund backing Medical, Diabetes and Hospital. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 1
- Last investment: Oct 2022
- Lead investor: 0%
- Last updated: Aug 2026

A&C Foelsgaard Alternativer ApS is a VC fund focused on Medical and Diabetes. A&C Foelsgaard Alternativer ApS is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 100% |
| Diabetes | 1 | 100% |
| Hospital | 1 | 100% |
| Health Care | 1 | 100% |
| Medical Device | 1 | 100% |

9 industries tracked in total.

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Eyenuk | Eyenuk, Inc. is a global artificial intelligence (AI) medical technology and services company and the leader in real-world AI Eye Screening for autonomous disease detection and AI Predictive Biomarkers™ for risk assessment and disease surveillance. Eyenuk’s first product, the EyeArt AI Eye Screening System, is the most extensively validated AItechnology for autonomous detection of diabetic retinopathy. Eyenuk is on a mission to screen every eye in the world to ensure timely diagnosis of life- and vision-threatening diseases, including diabetic retinopathy, glaucoma, age-related macular degeneration, stroke risk, cardiovascular risk and Alzheimer’s disease. | $26M | Series A | Oct 17, 2022 |  |

1 of 1 investments shown.

## Co-investors
- [AXA Investment Managers](https://shizune.co/investors/profile/axa-investment-managers) — VC Fund, 2 deals together
- [Kendall Capital Partners](https://shizune.co/investors/profile/kendall-capital-partners) — VC Fund, 1 deal together
- [KOFA Healthcare](https://shizune.co/investors/profile/kofa-healthcare-investments) — VC Fund, 1 deal together
- [T&W Medical](https://shizune.co/investors/profile/t-w-medical) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does A&C Foelsgaard Alternativer ApS invest in?

A&C Foelsgaard Alternativer ApS invests primarily in Medical, Diabetes and Hospital startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did A&C Foelsgaard Alternativer ApS last invest?

The most recent investment recorded for A&C Foelsgaard Alternativer ApS closed in Oct 2022. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co